

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mannose metabolic process (GO:0006013) | 3.80506487 |
| 2 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.69724264 |
| 3 | protein localization to endosome (GO:0036010) | 3.64350113 |
| 4 | regulation of extracellular matrix disassembly (GO:0010715) | 3.56268440 |
| 5 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.55183618 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.50568589 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 3.45129465 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 3.45129465 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.45129465 |
| 10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.45129465 |
| 11 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.45129465 |
| 12 | modulation by symbiont of host immune response (GO:0052553) | 3.45129465 |
| 13 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.34032226 |
| 14 | basement membrane organization (GO:0071711) | 3.25779108 |
| 15 | barbed-end actin filament capping (GO:0051016) | 3.18485074 |
| 16 | regulation of early endosome to late endosome transport (GO:2000641) | 3.17818058 |
| 17 | response to peptidoglycan (GO:0032494) | 3.12530980 |
| 18 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.10647982 |
| 19 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.10601130 |
| 20 | COPI coating of Golgi vesicle (GO:0048205) | 3.03157795 |
| 21 | Golgi transport vesicle coating (GO:0048200) | 3.03157795 |
| 22 | apoptotic process involved in morphogenesis (GO:0060561) | 3.00369846 |
| 23 | response to laminar fluid shear stress (GO:0034616) | 2.99698635 |
| 24 | negative regulation of cell killing (GO:0031342) | 2.97144956 |
| 25 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.97144956 |
| 26 | stress fiber assembly (GO:0043149) | 2.90444411 |
| 27 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.88504297 |
| 28 | positive regulation of receptor recycling (GO:0001921) | 2.87551724 |
| 29 | semaphorin-plexin signaling pathway (GO:0071526) | 2.80618535 |
| 30 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.76899246 |
| 31 | pinocytosis (GO:0006907) | 2.73642841 |
| 32 | macrophage activation involved in immune response (GO:0002281) | 2.65613794 |
| 33 | protein retention in ER lumen (GO:0006621) | 2.65378033 |
| 34 | adherens junction assembly (GO:0034333) | 2.64209825 |
| 35 | modulation by symbiont of host cellular process (GO:0044068) | 2.61000570 |
| 36 | detection of other organism (GO:0098543) | 2.57353515 |
| 37 | peptide catabolic process (GO:0043171) | 2.56981218 |
| 38 | epithelial cell-cell adhesion (GO:0090136) | 2.56581008 |
| 39 | maternal placenta development (GO:0001893) | 2.56569648 |
| 40 | glucose 6-phosphate metabolic process (GO:0051156) | 2.56297739 |
| 41 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.55160525 |
| 42 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.53643447 |
| 43 | detection of bacterium (GO:0016045) | 2.51719009 |
| 44 | glycosphingolipid catabolic process (GO:0046479) | 2.51143950 |
| 45 | regulation of cholesterol homeostasis (GO:2000188) | 2.50453982 |
| 46 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.49860612 |
| 47 | amyloid precursor protein catabolic process (GO:0042987) | 2.49446689 |
| 48 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.49339267 |
| 49 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.48256778 |
| 50 | NIK/NF-kappaB signaling (GO:0038061) | 2.47080427 |
| 51 | cell-substrate adherens junction assembly (GO:0007045) | 2.46458426 |
| 52 | focal adhesion assembly (GO:0048041) | 2.46458426 |
| 53 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.43936258 |
| 54 | regulation of leukocyte degranulation (GO:0043300) | 2.42777288 |
| 55 | negative regulation of fatty acid transport (GO:2000192) | 2.42752499 |
| 56 | regulation of extracellular matrix organization (GO:1903053) | 2.41537712 |
| 57 | positive regulation of histone deacetylation (GO:0031065) | 2.41204424 |
| 58 | hyaluronan catabolic process (GO:0030214) | 2.40569986 |
| 59 | pentose-phosphate shunt (GO:0006098) | 2.39458330 |
| 60 | modulation by virus of host process (GO:0019054) | 2.38540831 |
| 61 | negative regulation of viral release from host cell (GO:1902187) | 2.38228757 |
| 62 | detection of external biotic stimulus (GO:0098581) | 2.38183678 |
| 63 | detection of molecule of bacterial origin (GO:0032490) | 2.38074935 |
| 64 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.37251444 |
| 65 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.37236800 |
| 66 | negative regulation of cell size (GO:0045792) | 2.36713021 |
| 67 | cell-cell junction maintenance (GO:0045217) | 2.36171160 |
| 68 | activation of Rac GTPase activity (GO:0032863) | 2.34811425 |
| 69 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.33746741 |
| 70 | skin morphogenesis (GO:0043589) | 2.33426094 |
| 71 | cell-substrate junction assembly (GO:0007044) | 2.31972093 |
| 72 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.31784702 |
| 73 | neutrophil activation involved in immune response (GO:0002283) | 2.30687291 |
| 74 | embryonic process involved in female pregnancy (GO:0060136) | 2.30341650 |
| 75 | adhesion of symbiont to host (GO:0044406) | 2.30125110 |
| 76 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.28962327 |
| 77 | endothelial cell chemotaxis (GO:0035767) | 2.28847612 |
| 78 | apoptotic cell clearance (GO:0043277) | 2.28133700 |
| 79 | glycolipid catabolic process (GO:0019377) | 2.26893584 |
| 80 | amino sugar catabolic process (GO:0046348) | 2.25986716 |
| 81 | positive regulation of extracellular matrix organization (GO:1903055) | 2.24140051 |
| 82 | regulation of defense response to virus by virus (GO:0050690) | 2.23595871 |
| 83 | positive regulation of protein dephosphorylation (GO:0035307) | 2.21860939 |
| 84 | regulation of ARF GTPase activity (GO:0032312) | 2.21244305 |
| 85 | regulation of superoxide anion generation (GO:0032928) | 2.19491642 |
| 86 | signal complex assembly (GO:0007172) | 2.18872747 |
| 87 | response to muramyl dipeptide (GO:0032495) | 2.18306441 |
| 88 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.17750143 |
| 89 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.17384208 |
| 90 | glucose catabolic process (GO:0006007) | 2.15797866 |
| 91 | regulation of lipid kinase activity (GO:0043550) | 2.13782025 |
| 92 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.13255497 |
| 93 | leukocyte aggregation (GO:0070486) | 2.11951674 |
| 94 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.11918500 |
| 95 | negative regulation of adherens junction organization (GO:1903392) | 2.11666371 |
| 96 | negative regulation of focal adhesion assembly (GO:0051895) | 2.11666371 |
| 97 | negative regulation of cell junction assembly (GO:1901889) | 2.11666371 |
| 98 | positive regulation of lipid kinase activity (GO:0090218) | 2.10980741 |
| 99 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.09625594 |
| 100 | response to host defenses (GO:0052200) | 2.09625594 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.07015052 |
| 2 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.91817606 |
| 3 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.87154726 |
| 4 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.79279197 |
| 5 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.73808078 |
| 6 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.73420154 |
| 7 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.60805623 |
| 8 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.58602546 |
| 9 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.55297319 |
| 10 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 2.35749852 |
| 11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.28896730 |
| 12 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.23823567 |
| 13 | MYC_22102868_ChIP-Seq_BL_Human | 2.23296495 |
| 14 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.11492782 |
| 15 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.03989951 |
| 16 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.93185924 |
| 17 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.91821393 |
| 18 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.91432542 |
| 19 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.79998803 |
| 20 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.76854800 |
| 21 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.67808143 |
| 22 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.64401518 |
| 23 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.64401113 |
| 24 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.62124684 |
| 25 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.60194632 |
| 26 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.56518911 |
| 27 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.54920578 |
| 28 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.53404515 |
| 29 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.52647959 |
| 30 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.52582041 |
| 31 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.49906574 |
| 32 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.48104985 |
| 33 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.47874066 |
| 34 | MAF_26560356_Chip-Seq_TH1_Human | 1.47600643 |
| 35 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.47024926 |
| 36 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.45893036 |
| 37 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.45676670 |
| 38 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.44754851 |
| 39 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43884945 |
| 40 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.43080718 |
| 41 | P68_20966046_ChIP-Seq_HELA_Human | 1.42503938 |
| 42 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.42478089 |
| 43 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.42268420 |
| 44 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.39718480 |
| 45 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.38232618 |
| 46 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.37646532 |
| 47 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.37630305 |
| 48 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.35259248 |
| 49 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.35122514 |
| 50 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.34952447 |
| 51 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.34662536 |
| 52 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.33725436 |
| 53 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.33412269 |
| 54 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.32398567 |
| 55 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.31556968 |
| 56 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.31148921 |
| 57 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.26240921 |
| 58 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.25609311 |
| 59 | MAF_26560356_Chip-Seq_TH2_Human | 1.24812679 |
| 60 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.24767731 |
| 61 | SPI1_23127762_ChIP-Seq_K562_Human | 1.23043294 |
| 62 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.23039982 |
| 63 | ATF3_27146783_Chip-Seq_COLON_Human | 1.20364326 |
| 64 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.20079173 |
| 65 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.20077760 |
| 66 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.19829154 |
| 67 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.19631114 |
| 68 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19024415 |
| 69 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.18527583 |
| 70 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.18475629 |
| 71 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.17907882 |
| 72 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.16859287 |
| 73 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.16840751 |
| 74 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.14833160 |
| 75 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.14670234 |
| 76 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.13709013 |
| 77 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.12245689 |
| 78 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.11988104 |
| 79 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10915019 |
| 80 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.10521664 |
| 81 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.09555192 |
| 82 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.09011942 |
| 83 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.08942721 |
| 84 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.08410527 |
| 85 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.06085263 |
| 86 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.05570826 |
| 87 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.05536698 |
| 88 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04932996 |
| 89 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.04364323 |
| 90 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.03822498 |
| 91 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.03431144 |
| 92 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.03370081 |
| 93 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02464932 |
| 94 | GATA1_19941826_ChIP-Seq_K562_Human | 1.02350882 |
| 95 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01574503 |
| 96 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01134397 |
| 97 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.99308160 |
| 98 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97873321 |
| 99 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.97869896 |
| 100 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97812348 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 3.84283353 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.42536520 |
| 3 | MP0005451_abnormal_body_composition | 2.86333545 |
| 4 | MP0009840_abnormal_foam_cell | 2.84087961 |
| 5 | MP0003303_peritoneal_inflammation | 2.72203719 |
| 6 | MP0003436_decreased_susceptibility_to | 2.70347361 |
| 7 | MP0008438_abnormal_cutaneous_collagen | 2.65588913 |
| 8 | MP0003172_abnormal_lysosome_physiology | 2.59963359 |
| 9 | MP0003300_gastrointestinal_ulcer | 2.57179251 |
| 10 | MP0001849_ear_inflammation | 2.34530654 |
| 11 | MP0003566_abnormal_cell_adhesion | 2.26677270 |
| 12 | MP0004858_abnormal_nervous_system | 2.22251849 |
| 13 | MP0008260_abnormal_autophagy | 2.19892680 |
| 14 | MP0002254_reproductive_system_inflammat | 2.12565948 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.06717955 |
| 16 | MP0010234_abnormal_vibrissa_follicle | 1.96117418 |
| 17 | MP0003279_aneurysm | 1.93257404 |
| 18 | MP0004510_myositis | 1.91662964 |
| 19 | MP0004272_abnormal_basement_membrane | 1.86206978 |
| 20 | MP0003724_increased_susceptibility_to | 1.80788390 |
| 21 | MP0004264_abnormal_extraembryonic_tissu | 1.80484497 |
| 22 | MP0005409_darkened_coat_color | 1.78777496 |
| 23 | MP0005257_abnormal_intraocular_pressure | 1.74224837 |
| 24 | MP0001533_abnormal_skeleton_physiology | 1.70220828 |
| 25 | MP0005076_abnormal_cell_differentiation | 1.68555497 |
| 26 | MP0000858_altered_metastatic_potential | 1.64374140 |
| 27 | MP0002419_abnormal_innate_immunity | 1.59638807 |
| 28 | MP0004947_skin_inflammation | 1.58228225 |
| 29 | MP0003091_abnormal_cell_migration | 1.54968087 |
| 30 | MP0000678_abnormal_parathyroid_gland | 1.51877068 |
| 31 | MP0002998_abnormal_bone_remodeling | 1.51681910 |
| 32 | MP0003453_abnormal_keratinocyte_physiol | 1.51155657 |
| 33 | MP0003183_abnormal_peptide_metabolism | 1.48502288 |
| 34 | MP0002877_abnormal_melanocyte_morpholog | 1.47279960 |
| 35 | MP0006082_CNS_inflammation | 1.45905770 |
| 36 | MP0005025_abnormal_response_to | 1.42199760 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.40070384 |
| 38 | MP0001958_emphysema | 1.39651603 |
| 39 | MP0009278_abnormal_bone_marrow | 1.38773874 |
| 40 | MP0005464_abnormal_platelet_physiology | 1.36247756 |
| 41 | MP0000767_abnormal_smooth_muscle | 1.30318089 |
| 42 | MP0005360_urolithiasis | 1.28247178 |
| 43 | MP0000685_abnormal_immune_system | 1.26577074 |
| 44 | MP0005023_abnormal_wound_healing | 1.26468043 |
| 45 | MP0009333_abnormal_splenocyte_physiolog | 1.25642414 |
| 46 | MP0002089_abnormal_postnatal_growth/wei | 1.17408225 |
| 47 | MP0001790_abnormal_immune_system | 1.13691998 |
| 48 | MP0005387_immune_system_phenotype | 1.13691998 |
| 49 | MP0005000_abnormal_immune_tolerance | 1.12141197 |
| 50 | MP0002796_impaired_skin_barrier | 1.10522987 |
| 51 | MP0004185_abnormal_adipocyte_glucose | 1.10052762 |
| 52 | MP0003828_pulmonary_edema | 1.09939822 |
| 53 | MP0005390_skeleton_phenotype | 1.08737632 |
| 54 | MP0009785_altered_susceptibility_to | 1.06356023 |
| 55 | MP0000604_amyloidosis | 1.05265296 |
| 56 | MP0000490_abnormal_crypts_of | 1.04618960 |
| 57 | MP0003075_altered_response_to | 1.04587625 |
| 58 | MP0003329_amyloid_beta_deposits | 1.02729744 |
| 59 | MP0001873_stomach_inflammation | 0.97493961 |
| 60 | MP0008004_abnormal_stomach_pH | 0.97335530 |
| 61 | MP0005083_abnormal_biliary_tract | 0.96774239 |
| 62 | MP0009384_cardiac_valve_regurgitation | 0.96505225 |
| 63 | MP0004233_abnormal_muscle_weight | 0.96363501 |
| 64 | MP0001835_abnormal_antigen_presentation | 0.95715186 |
| 65 | MP0010368_abnormal_lymphatic_system | 0.95586271 |
| 66 | MP0002139_abnormal_hepatobiliary_system | 0.94170381 |
| 67 | MP0001819_abnormal_immune_cell | 0.93046636 |
| 68 | MP0002933_joint_inflammation | 0.93008862 |
| 69 | MP0002452_abnormal_antigen_presenting | 0.92998359 |
| 70 | MP0002723_abnormal_immune_serum | 0.92502420 |
| 71 | MP0003866_abnormal_defecation | 0.91963023 |
| 72 | MP0002420_abnormal_adaptive_immunity | 0.91913462 |
| 73 | MP0001845_abnormal_inflammatory_respons | 0.91145728 |
| 74 | MP0002148_abnormal_hypersensitivity_rea | 0.90736387 |
| 75 | MP0008469_abnormal_protein_level | 0.90682888 |
| 76 | MP0001915_intracranial_hemorrhage | 0.90302246 |
| 77 | MP0005310_abnormal_salivary_gland | 0.88889177 |
| 78 | MP0000343_altered_response_to | 0.86254270 |
| 79 | MP0003448_altered_tumor_morphology | 0.83165189 |
| 80 | MP0002405_respiratory_system_inflammati | 0.82585862 |
| 81 | MP0004381_abnormal_hair_follicle | 0.81868484 |
| 82 | MP0003795_abnormal_bone_structure | 0.81193838 |
| 83 | MP0001800_abnormal_humoral_immune | 0.78800134 |
| 84 | MP0005365_abnormal_bile_salt | 0.78688245 |
| 85 | MP0010352_gastrointestinal_tract_polyps | 0.78088046 |
| 86 | MP0001663_abnormal_digestive_system | 0.78078703 |
| 87 | MP0002060_abnormal_skin_morphology | 0.77860252 |
| 88 | MP0002896_abnormal_bone_mineralization | 0.77079533 |
| 89 | MP0002249_abnormal_larynx_morphology | 0.76735182 |
| 90 | MP0002132_abnormal_respiratory_system | 0.74992663 |
| 91 | MP0005375_adipose_tissue_phenotype | 0.73890436 |
| 92 | MP0003763_abnormal_thymus_physiology | 0.73132919 |
| 93 | MP0000249_abnormal_blood_vessel | 0.72875521 |
| 94 | MP0005501_abnormal_skin_physiology | 0.72315248 |
| 95 | MP0005666_abnormal_adipose_tissue | 0.71328191 |
| 96 | MP0005166_decreased_susceptibility_to | 0.70812562 |
| 97 | MP0006054_spinal_hemorrhage | 0.70553082 |
| 98 | MP0005381_digestive/alimentary_phenotyp | 0.69446573 |
| 99 | MP0001614_abnormal_blood_vessel | 0.69291031 |
| 100 | MP0001348_abnormal_lacrimal_gland | 0.68008040 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 3.38412727 |
| 2 | Eczematoid dermatitis (HP:0000976) | 3.31880863 |
| 3 | Premature rupture of membranes (HP:0001788) | 3.31429609 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.22126688 |
| 5 | Abnormality of glycolipid metabolism (HP:0010969) | 3.22126688 |
| 6 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.22126688 |
| 7 | Dysostosis multiplex (HP:0000943) | 3.12913647 |
| 8 | Abnormality of macrophages (HP:0004311) | 3.07638594 |
| 9 | Cerebral aneurysm (HP:0004944) | 2.95694567 |
| 10 | Vertebral compression fractures (HP:0002953) | 2.83352414 |
| 11 | J-shaped sella turcica (HP:0002680) | 2.79036156 |
| 12 | Flat acetabular roof (HP:0003180) | 2.76036573 |
| 13 | Cervical subluxation (HP:0003308) | 2.75081384 |
| 14 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.70208475 |
| 15 | Mucopolysacchariduria (HP:0008155) | 2.70208475 |
| 16 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.67015115 |
| 17 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.67015115 |
| 18 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.67015115 |
| 19 | Thin bony cortex (HP:0002753) | 2.58785786 |
| 20 | Hemorrhage of the eye (HP:0011885) | 2.55047264 |
| 21 | Obstructive sleep apnea (HP:0002870) | 2.54944654 |
| 22 | Distal upper limb amyotrophy (HP:0007149) | 2.53027441 |
| 23 | Upper limb amyotrophy (HP:0009129) | 2.53027441 |
| 24 | Broad face (HP:0000283) | 2.46621068 |
| 25 | Increased cerebral lipofuscin (HP:0011813) | 2.45010813 |
| 26 | Hyperacusis (HP:0010780) | 2.42505625 |
| 27 | Achilles tendon contracture (HP:0001771) | 2.38191874 |
| 28 | Disproportionate tall stature (HP:0001519) | 2.33216829 |
| 29 | Recurrent abscess formation (HP:0002722) | 2.30564612 |
| 30 | Abnormality of the Achilles tendon (HP:0005109) | 2.29328775 |
| 31 | Loss of speech (HP:0002371) | 2.29167248 |
| 32 | Deep venous thrombosis (HP:0002625) | 2.28084644 |
| 33 | Distal lower limb muscle weakness (HP:0009053) | 2.26893975 |
| 34 | Blue sclerae (HP:0000592) | 2.24579002 |
| 35 | Increased connective tissue (HP:0009025) | 2.19270784 |
| 36 | Systemic lupus erythematosus (HP:0002725) | 2.19111906 |
| 37 | Vacuolated lymphocytes (HP:0001922) | 2.17262687 |
| 38 | Distal lower limb amyotrophy (HP:0008944) | 2.15529793 |
| 39 | Peritonitis (HP:0002586) | 2.13811673 |
| 40 | Spontaneous hematomas (HP:0007420) | 2.11717621 |
| 41 | Pathologic fracture (HP:0002756) | 2.09147142 |
| 42 | Axonal loss (HP:0003447) | 2.07949006 |
| 43 | Purpura (HP:0000979) | 2.07112061 |
| 44 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.05981709 |
| 45 | Recurrent bacterial skin infections (HP:0005406) | 2.04823561 |
| 46 | Shallow orbits (HP:0000586) | 2.04060511 |
| 47 | Stridor (HP:0010307) | 2.03322799 |
| 48 | Aneurysm (HP:0002617) | 2.03175988 |
| 49 | Cellulitis (HP:0100658) | 2.03120623 |
| 50 | Myocardial infarction (HP:0001658) | 2.00395763 |
| 51 | Asymmetric septal hypertrophy (HP:0001670) | 2.00109344 |
| 52 | Obstructive lung disease (HP:0006536) | 1.98817336 |
| 53 | Chronic obstructive pulmonary disease (HP:0006510) | 1.98817336 |
| 54 | Gingivitis (HP:0000230) | 1.98685877 |
| 55 | Ulnar bowing (HP:0003031) | 1.96545073 |
| 56 | Increased variability in muscle fiber diameter (HP:0003557) | 1.95867950 |
| 57 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.95740149 |
| 58 | Hand muscle atrophy (HP:0009130) | 1.92264814 |
| 59 | Malnutrition (HP:0004395) | 1.92020625 |
| 60 | Dilatation of the ascending aorta (HP:0005111) | 1.90449231 |
| 61 | Nuclear cataract (HP:0100018) | 1.88913724 |
| 62 | Mitral regurgitation (HP:0001653) | 1.88675481 |
| 63 | Abnormality of the nasal mucosa (HP:0000433) | 1.88497607 |
| 64 | Genu recurvatum (HP:0002816) | 1.88284048 |
| 65 | Myositis (HP:0100614) | 1.84271983 |
| 66 | Broad metatarsal (HP:0001783) | 1.83535199 |
| 67 | Polycythemia (HP:0001901) | 1.83129542 |
| 68 | Fragile skin (HP:0001030) | 1.82978128 |
| 69 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.81411740 |
| 70 | Polygenic inheritance (HP:0010982) | 1.80956608 |
| 71 | Abnormal vertebral ossification (HP:0100569) | 1.79904791 |
| 72 | Ankle contracture (HP:0006466) | 1.79827656 |
| 73 | Joint stiffness (HP:0001387) | 1.79643222 |
| 74 | Esophageal varix (HP:0002040) | 1.79420368 |
| 75 | Amyloidosis (HP:0011034) | 1.79371215 |
| 76 | Bone pain (HP:0002653) | 1.78825583 |
| 77 | Orchitis (HP:0100796) | 1.78573465 |
| 78 | Interstitial pulmonary disease (HP:0006530) | 1.76746367 |
| 79 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.75427021 |
| 80 | Abnormality of the thoracic spine (HP:0100711) | 1.74989474 |
| 81 | Biconcave vertebral bodies (HP:0004586) | 1.74338177 |
| 82 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.71320450 |
| 83 | Gastrointestinal infarctions (HP:0005244) | 1.70533633 |
| 84 | Flared iliac wings (HP:0002869) | 1.70239804 |
| 85 | Easy fatigability (HP:0003388) | 1.70124814 |
| 86 | Long toe (HP:0010511) | 1.70049976 |
| 87 | Abdominal distention (HP:0003270) | 1.69267489 |
| 88 | Xanthomatosis (HP:0000991) | 1.67506716 |
| 89 | Spinal rigidity (HP:0003306) | 1.66961222 |
| 90 | Bulbar palsy (HP:0001283) | 1.66666137 |
| 91 | Coxa vara (HP:0002812) | 1.66460761 |
| 92 | Deformed sella turcica (HP:0002681) | 1.66414675 |
| 93 | Nonimmune hydrops fetalis (HP:0001790) | 1.65457876 |
| 94 | Arterial tortuosity (HP:0005116) | 1.65444193 |
| 95 | Vascular tortuosity (HP:0004948) | 1.65200558 |
| 96 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.65181081 |
| 97 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.64486325 |
| 98 | Emphysema (HP:0002097) | 1.64044457 |
| 99 | Cerebral inclusion bodies (HP:0100314) | 1.63722542 |
| 100 | Lymphangioma (HP:0100764) | 1.63064480 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.50913832 |
| 2 | ERN1 | 3.60751406 |
| 3 | SIK1 | 3.27342487 |
| 4 | IRAK3 | 2.85586413 |
| 5 | PRPF4B | 2.74005308 |
| 6 | SMG1 | 2.59640132 |
| 7 | FGFR4 | 2.19741829 |
| 8 | MAP2K3 | 2.15487319 |
| 9 | EPHA2 | 2.06318603 |
| 10 | RIPK1 | 2.04709412 |
| 11 | MAP4K1 | 1.91275270 |
| 12 | PKN2 | 1.90401245 |
| 13 | ICK | 1.90238327 |
| 14 | MAP3K3 | 1.82388042 |
| 15 | EPHB1 | 1.82037394 |
| 16 | TAOK1 | 1.76630858 |
| 17 | IRAK4 | 1.63947865 |
| 18 | PAK4 | 1.63098387 |
| 19 | MAP3K11 | 1.61608067 |
| 20 | RIPK4 | 1.58848773 |
| 21 | EEF2K | 1.56396134 |
| 22 | PTK6 | 1.52134977 |
| 23 | TTN | 1.46564807 |
| 24 | TAOK2 | 1.44410480 |
| 25 | TESK1 | 1.40789015 |
| 26 | PRKD2 | 1.39300544 |
| 27 | ZAP70 | 1.35820253 |
| 28 | MAP3K10 | 1.34159135 |
| 29 | PDGFRA | 1.31418875 |
| 30 | TYK2 | 1.28804414 |
| 31 | CDC42BPA | 1.28775116 |
| 32 | MARK2 | 1.20691320 |
| 33 | CSK | 1.20634477 |
| 34 | MAP3K1 | 1.20067135 |
| 35 | NME2 | 1.15202904 |
| 36 | LMTK2 | 1.14683018 |
| 37 | TBK1 | 1.13949416 |
| 38 | DDR2 | 1.12931490 |
| 39 | PDPK1 | 1.12556851 |
| 40 | PTK2 | 1.11902803 |
| 41 | TESK2 | 1.11360541 |
| 42 | PRKG2 | 1.10368151 |
| 43 | MAP3K13 | 1.08143045 |
| 44 | KSR2 | 1.07799236 |
| 45 | GRK6 | 1.07764358 |
| 46 | IRAK2 | 1.05365418 |
| 47 | MST1R | 1.00885510 |
| 48 | RPS6KA2 | 0.95314484 |
| 49 | CDK12 | 0.92175857 |
| 50 | BMX | 0.91150112 |
| 51 | BLK | 0.90771531 |
| 52 | TNK2 | 0.90080071 |
| 53 | JAK3 | 0.83986081 |
| 54 | TGFBR2 | 0.79220957 |
| 55 | MTOR | 0.78959047 |
| 56 | EPHB2 | 0.78057543 |
| 57 | LRRK2 | 0.77016222 |
| 58 | PRKD3 | 0.75919509 |
| 59 | TYRO3 | 0.72911930 |
| 60 | RPS6KL1 | 0.71361607 |
| 61 | RPS6KC1 | 0.71361607 |
| 62 | FGR | 0.68303720 |
| 63 | FES | 0.68166626 |
| 64 | KDR | 0.68143917 |
| 65 | PDK1 | 0.67949048 |
| 66 | MAP3K6 | 0.67408954 |
| 67 | FGFR3 | 0.65002389 |
| 68 | ARAF | 0.64111157 |
| 69 | MAP3K14 | 0.62374422 |
| 70 | DYRK1B | 0.61672634 |
| 71 | MAP3K8 | 0.61658733 |
| 72 | STK38 | 0.61453716 |
| 73 | MAP2K2 | 0.61009340 |
| 74 | SIK3 | 0.60771253 |
| 75 | CAMK1D | 0.60457767 |
| 76 | HCK | 0.60154639 |
| 77 | HIPK2 | 0.57436068 |
| 78 | BTK | 0.55508725 |
| 79 | RET | 0.52732500 |
| 80 | RPS6KA6 | 0.49021327 |
| 81 | PDGFRB | 0.48936198 |
| 82 | MATK | 0.47838036 |
| 83 | MAP3K2 | 0.46645918 |
| 84 | IRAK1 | 0.46221666 |
| 85 | MAP3K7 | 0.45826604 |
| 86 | MAPK11 | 0.45365694 |
| 87 | MAPK12 | 0.45077140 |
| 88 | JAK1 | 0.42054044 |
| 89 | NTRK1 | 0.41152039 |
| 90 | CSF1R | 0.40414897 |
| 91 | ILK | 0.40239311 |
| 92 | CHUK | 0.39167971 |
| 93 | BRAF | 0.38172122 |
| 94 | IKBKE | 0.36375845 |
| 95 | MET | 0.35785939 |
| 96 | TIE1 | 0.35107647 |
| 97 | SGK3 | 0.34810296 |
| 98 | MAPKAPK2 | 0.34761611 |
| 99 | MAPK7 | 0.32555868 |
| 100 | SIK2 | 0.31867194 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.52541600 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.68848914 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.41713493 |
| 4 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.22375815 |
| 5 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.83108749 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.82363243 |
| 7 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.80123848 |
| 8 | Lysosome_Homo sapiens_hsa04142 | 1.73884602 |
| 9 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.62125666 |
| 10 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.58474548 |
| 11 | Galactose metabolism_Homo sapiens_hsa00052 | 1.55468003 |
| 12 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.50296734 |
| 13 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.47679855 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 1.43777894 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.42598618 |
| 16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.42419451 |
| 17 | Bladder cancer_Homo sapiens_hsa05219 | 1.41704333 |
| 18 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.31687254 |
| 19 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.23089311 |
| 20 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.22902201 |
| 21 | Prion diseases_Homo sapiens_hsa05020 | 1.22374712 |
| 22 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.20952696 |
| 23 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.20392896 |
| 24 | Hepatitis C_Homo sapiens_hsa05160 | 1.20187888 |
| 25 | Amoebiasis_Homo sapiens_hsa05146 | 1.19565522 |
| 26 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.16705985 |
| 27 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.16446536 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.15586669 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.14616738 |
| 30 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.13660865 |
| 31 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.13312472 |
| 32 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.12801368 |
| 33 | Endometrial cancer_Homo sapiens_hsa05213 | 1.11235010 |
| 34 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.10556994 |
| 35 | Tuberculosis_Homo sapiens_hsa05152 | 1.10120269 |
| 36 | Malaria_Homo sapiens_hsa05144 | 1.06939242 |
| 37 | Focal adhesion_Homo sapiens_hsa04510 | 1.06188052 |
| 38 | Salmonella infection_Homo sapiens_hsa05132 | 1.01963829 |
| 39 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.99756519 |
| 40 | Endocytosis_Homo sapiens_hsa04144 | 0.97470336 |
| 41 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.97185648 |
| 42 | Influenza A_Homo sapiens_hsa05164 | 0.96533965 |
| 43 | Thyroid cancer_Homo sapiens_hsa05216 | 0.94795801 |
| 44 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.94674400 |
| 45 | Shigellosis_Homo sapiens_hsa05131 | 0.94529648 |
| 46 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.94015412 |
| 47 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.92865488 |
| 48 | Insulin resistance_Homo sapiens_hsa04931 | 0.92143037 |
| 49 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.92098270 |
| 50 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.91414116 |
| 51 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.91212985 |
| 52 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.90037989 |
| 53 | Hepatitis B_Homo sapiens_hsa05161 | 0.89986051 |
| 54 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.88243947 |
| 55 | Pertussis_Homo sapiens_hsa05133 | 0.87508100 |
| 56 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.85604286 |
| 57 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.84750706 |
| 58 | Apoptosis_Homo sapiens_hsa04210 | 0.83569478 |
| 59 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.81566104 |
| 60 | Phagosome_Homo sapiens_hsa04145 | 0.80428979 |
| 61 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.80370104 |
| 62 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.80034130 |
| 63 | Prostate cancer_Homo sapiens_hsa05215 | 0.79601598 |
| 64 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.78246391 |
| 65 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.77381408 |
| 66 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.76924858 |
| 67 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.76308278 |
| 68 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75957654 |
| 69 | Platelet activation_Homo sapiens_hsa04611 | 0.74749321 |
| 70 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.74250248 |
| 71 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.74201488 |
| 72 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.72844361 |
| 73 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.72764338 |
| 74 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.71315558 |
| 75 | Measles_Homo sapiens_hsa05162 | 0.70808762 |
| 76 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70017707 |
| 77 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.69798453 |
| 78 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.69518963 |
| 79 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.65570868 |
| 80 | Glioma_Homo sapiens_hsa05214 | 0.62744295 |
| 81 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.62697715 |
| 82 | Adherens junction_Homo sapiens_hsa04520 | 0.62430982 |
| 83 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.59884612 |
| 84 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.59791974 |
| 85 | Viral myocarditis_Homo sapiens_hsa05416 | 0.59548551 |
| 86 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.59461359 |
| 87 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.59193829 |
| 88 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.58795050 |
| 89 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.58264761 |
| 90 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.57723127 |
| 91 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.57718823 |
| 92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57097466 |
| 93 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.55860453 |
| 94 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.54535252 |
| 95 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.53515480 |
| 96 | Colorectal cancer_Homo sapiens_hsa05210 | 0.52768305 |
| 97 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.51635252 |
| 98 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50014107 |
| 99 | Legionellosis_Homo sapiens_hsa05134 | 0.48686911 |
| 100 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.46832750 |

